Business Description
Idorsia Ltd
ISIN : CH0363463438
Share Class Description:
FRA:19T: Registered SharesCompare
Compare
Traded in other countries / regions
IDIA.Switzerland0RQE.UKIDRSF.USA19T.Germany IPO Date
2017-06-19Description
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | -1.27 | |||||
| Debt-to-Equity | -1.45 | |||||
| Debt-to-EBITDA | -3.69 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -7.7 | |||||
| Beneish M-Score | 2.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.8 | |||||
| 3-Year EBITDA Growth Rate | -7.7 | |||||
| 3-Year EPS without NRI Growth Rate | -9 | |||||
| 3-Year FCF Growth Rate | -10.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -31.23 | |||||
| Future 3-5Y Total Revenue Growth Rate | 35.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.21 | |||||
| Quick Ratio | 1.02 | |||||
| Cash Ratio | 0.86 | |||||
| Days Inventory | 1785.29 | |||||
| Days Sales Outstanding | 55.83 | |||||
| Days Payable | 894.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -9.23 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.92 | |||||
| Operating Margin % | -336.1 | |||||
| Net Margin % | -202.54 | |||||
| FCF Margin % | -403.27 | |||||
| ROA % | -49.11 | |||||
| ROIC % | -135.16 | |||||
| ROC (Joel Greenblatt) % | -148.43 | |||||
| ROCE % | -62.03 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.9 | |||||
| EV-to-EBIT | -3.72 | |||||
| EV-to-EBITDA | -3.95 | |||||
| EV-to-Revenue | 6.99 | |||||
| EV-to-FCF | -1.72 | |||||
| Earnings Yield (Greenblatt) % | -26.88 | |||||
| FCF Yield % | -213.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Idorsia Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 189.666 | ||
| EPS (TTM) (€) | -2.111 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (€) | 0 | ||
| 20-Day SMA (€) | 19.6 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (€) | 19.6 - 19.6 | ||
| Shares Outstanding (Mil) | 178.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Idorsia Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Idorsia Ltd Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Idorsia Ltd Frequently Asked Questions
What is Idorsia Ltd(FRA:19T)'s stock price today?
The current price of FRA:19T is €19.60. The 52 week high of FRA:19T is €19.60 and 52 week low is €19.60.
When is next earnings date of Idorsia Ltd(FRA:19T)?
The next earnings date of Idorsia Ltd(FRA:19T) is .
Does Idorsia Ltd(FRA:19T) pay dividends? If so, how much?
Idorsia Ltd(FRA:19T) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers